{"url_path":"/sec/tak/10-k/2026/item-8","section_key":"item-8","section_title":"Item 8 Financial Information","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-06-17","source_url":"https://www.sec.gov/Archives/edgar/data/1395064/0001395064-26-000177-index.html","accession_number":"0001395064-26-000177","cik":"0001395064","ticker":"TAK","issuer_name":"TAKEDA PHARMACEUTICAL CO LTD","edgar_url":"https://www.sec.gov/Archives/edgar/data/1395064/0001395064-26-000177-index.html","primary_entity_key":"0001395064","primary_entity_name":"TAKEDA PHARMACEUTICAL CO LTD"},"word_count":352,"has_tables":true,"body_markdown":"Item 8. Financial Information\n\nA. Consolidated Statements and Other Financial Information\n\nOur audited consolidated financial statements are included under “Item 18—Financial Statements.”\n\nLegal Proceedings\n\nThe information required by this item is set forth in our consolidated financial statements included in this annual report. See Note 31 to our audited consolidated financial statements for a detailed discussion of legal proceedings.\n\nDividends\n\nTakeda’s policy in the allocation of capital is as follows:\n\n• Invest in growth drivers; and\n\n• Shareholder returns.\n\nWith respect to \"Invest in growth drivers\", Takeda makes strategic investments in new product launches, internal and external opportunities to enhance its pipeline, and plasma-derived therapies. With regard to \"Shareholder returns\", Takeda has adopted a progressive dividend policy of increasing or maintaining the annual dividend per share each year, alongside share buybacks when appropriate.\n\nAs noted above, the return of capital to shareholders is one of the focus areas for our management, and we believe our dividend policy is an important tool for accomplishing our goals.\n\ni) Dividends declared and paid during the previous fiscal years and the current fiscal year\n\nDividends declared and paidJPY (billions)\nTotal dividendsDividends per share JPYRecord dateEffective date\n\nApril 1, 2023, to March 31, 2024\n\nQ1 2023¥140.5¥90.00 March 31, 2023June 29, 2023\n\nQ3 2023148.094.00 September 30, 2023December 1, 2023\n\nApril 1, 2024, to March 31, 2025\n\nQ1 2024148.094.00 March 31, 2024June 27, 2024\n\nQ3 2024155.998.00 September 30, 2024December 2, 2024\n\nApril 1, 2025, to March 31, 2026\n\nQ1 2025154.898.00 March 31, 2025June 26, 2025\n\nQ3 2025158.5100.00 September 30, 2025December 1, 2025\n\nii) Dividends declared whose record date falls in the fiscal year ended March 31, 2026 and the effective date falls in the following fiscal year\n\nMatters with respect to dividends on shares of common stock will be proposed at the Annual General Meeting of Shareholders to be held on June 24, 2026.\n\nDividends to be submittedJPY (billions)\nTotal dividendsDividends per share JPYRecord dateEffective date\n\nApril 1, 2026, to March 31, 2027\n\nQ1 2026¥158.5¥100.00March 31, 2026June 25, 2026\n\nB. Significant Changes\n\nNo significant change has occurred since the date of the annual financial statements.\n\n119\n\n[Table of Contents](#i89761be648564855b53fa24df8e6ee90_10)"}